DBV Technologies - Aktienkurs

Aktienkurs
10.80
Täglich Wechseln
-0.03 -0.31%
Monatlich
11.46%
Jährlich
170.00%
Q3 Prognose
10.54

Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 20.98 -1.08 -4.90% 18.06% 2025-07-11
Alnylam Pharmaceuticals 314.94 -7.70 -2.39% 20.89% 2025-07-11
Amarin 16.93 -0.39 -2.25% 8.43% 2025-07-11
BioMarin Pharmaceutical 58.10 -0.72 -1.22% -31.66% 2025-07-11
DBV Technologies 10.80 -0.03 -0.31% 170.00% 2025-07-11
Halozyme Therapeutics 57.15 -0.48 -0.83% 7.47% 2025-07-11
Incyte 68.59 -1.75 -2.49% 7.74% 2025-07-11
Insmed 98.18 1.52 1.57% 27.99% 2025-07-11
Ionis Pharmaceuticals 41.73 -0.65 -1.53% -13.06% 2025-07-11
Neurocrine Biosciences 133.46 -1.46 -1.08% -9.47% 2025-07-11
PTC Therapeutics 48.55 -0.97 -1.96% 45.93% 2025-07-11
Ultragenyx Pharmaceutical 29.51 -1.53 -4.91% -34.63% 2025-07-11
Sarepta Therapeutics 18.17 -0.90 -4.69% -88.05% 2025-07-11
United Therapeutics 295.52 -4.64 -1.55% -8.05% 2025-07-11

Preis Tag Jahr Datum
USND 20586 -45.14 -0.22% 11.89% 2025-07-11